UniProt ID | TFDP1_HUMAN | |
---|---|---|
UniProt AC | Q14186 | |
Protein Name | Transcription factor Dp-1 | |
Gene Name | TFDP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 410 | |
Subcellular Localization | Nucleus . Cytoplasm . Shuttles between the cytoplasm and nucleus and translocates into the nuclear compartment upon heterodimerization with E2F1. | |
Protein Description | Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. [PubMed: 8405995] | |
Protein Sequence | MAKDAGLIEANGELKVFIDQNLSPGKGVVSLVAVHPSTVNPLGKQLLPKTFGQSNVNIAQQVVIGTPQRPAASNTLVVGSPHTPSTHFASQNQPSDSSPWSAGKRNRKGEKNGKGLRHFSMKVCEKVQRKGTTSYNEVADELVAEFSAADNHILPNESAYDQKNIRRRVYDALNVLMAMNIISKEKKEIKWIGLPTNSAQECQNLEVERQRRLERIKQKQSQLQELILQQIAFKNLVQRNRHAEQQASRPPPPNSVIHLPFIIVNTSKKTVIDCSISNDKFEYLFNFDNTFEIHDDIEVLKRMGMACGLESGSCSAEDLKMARSLVPKALEPYVTEMAQGTVGGVFITTAGSTSNGTRFSASDLTNGADGMLATSSNGSQYSGSRVETPVSYVGEDDEEDDDFNENDEDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Acetylation | -----MAKDAGLIEA -----CCCCCCEEEE | 46.98 | 19608861 | |
3 | Ubiquitination | -----MAKDAGLIEA -----CCCCCCEEEE | 46.98 | 19608861 | |
23 | Phosphorylation | VFIDQNLSPGKGVVS EEEECCCCCCCCEEE | 38.87 | 19664994 | |
26 | Ubiquitination | DQNLSPGKGVVSLVA ECCCCCCCCEEEEEE | 52.49 | - | |
27 | Ubiquitination | QNLSPGKGVVSLVAV CCCCCCCCEEEEEEE | 30.86 | - | |
30 | Phosphorylation | SPGKGVVSLVAVHPS CCCCCEEEEEEECHH | 18.08 | 28464451 | |
37 | Phosphorylation | SLVAVHPSTVNPLGK EEEEECHHHCCCCCH | 30.06 | 24732914 | |
38 | Phosphorylation | LVAVHPSTVNPLGKQ EEEECHHHCCCCCHH | 28.84 | 24732914 | |
44 | Ubiquitination | STVNPLGKQLLPKTF HHCCCCCHHHCCCCC | 45.51 | 21890473 | |
44 | Acetylation | STVNPLGKQLLPKTF HHCCCCCHHHCCCCC | 45.51 | 26051181 | |
44 | Ubiquitination | STVNPLGKQLLPKTF HHCCCCCHHHCCCCC | 45.51 | 21890473 | |
73 | Phosphorylation | TPQRPAASNTLVVGS CCCCCCCCCEEEECC | 32.24 | 20873877 | |
75 | Phosphorylation | QRPAASNTLVVGSPH CCCCCCCEEEECCCC | 20.59 | 28985074 | |
80 | Phosphorylation | SNTLVVGSPHTPSTH CCEEEECCCCCCCCC | 11.25 | 20873877 | |
83 | Phosphorylation | LVVGSPHTPSTHFAS EEECCCCCCCCCCCC | 23.48 | 28985074 | |
85 | Phosphorylation | VGSPHTPSTHFASQN ECCCCCCCCCCCCCC | 35.35 | 20873877 | |
86 | Phosphorylation | GSPHTPSTHFASQNQ CCCCCCCCCCCCCCC | 23.40 | 20873877 | |
90 | Phosphorylation | TPSTHFASQNQPSDS CCCCCCCCCCCCCCC | 28.81 | 20873877 | |
91 | Ubiquitination | PSTHFASQNQPSDSS CCCCCCCCCCCCCCC | 49.50 | - | |
92 | Ubiquitination | STHFASQNQPSDSSP CCCCCCCCCCCCCCC | 53.92 | - | |
95 | Phosphorylation | FASQNQPSDSSPWSA CCCCCCCCCCCCCCC | 40.12 | 20873877 | |
95 | Ubiquitination | FASQNQPSDSSPWSA CCCCCCCCCCCCCCC | 40.12 | - | |
97 | Phosphorylation | SQNQPSDSSPWSAGK CCCCCCCCCCCCCCC | 42.51 | 20873877 | |
98 | Phosphorylation | QNQPSDSSPWSAGKR CCCCCCCCCCCCCCC | 35.06 | 20873877 | |
101 | Phosphorylation | PSDSSPWSAGKRNRK CCCCCCCCCCCCCCC | 30.44 | 20873877 | |
104 | Acetylation | SSPWSAGKRNRKGEK CCCCCCCCCCCCCCC | 46.33 | 26051181 | |
120 | Phosphorylation | GKGLRHFSMKVCEKV CCCHHHHHHHHHHHH | 16.15 | 24719451 | |
122 | Ubiquitination | GLRHFSMKVCEKVQR CHHHHHHHHHHHHHH | 42.40 | - | |
122 | Ubiquitination | GLRHFSMKVCEKVQR CHHHHHHHHHHHHHH | 42.40 | - | |
124 | Ubiquitination | RHFSMKVCEKVQRKG HHHHHHHHHHHHHHC | 3.32 | - | |
126 | Acetylation | FSMKVCEKVQRKGTT HHHHHHHHHHHHCCC | 38.24 | 25953088 | |
126 | Ubiquitination | FSMKVCEKVQRKGTT HHHHHHHHHHHHCCC | 38.24 | - | |
130 | Ubiquitination | VCEKVQRKGTTSYNE HHHHHHHHCCCCHHH | 43.44 | - | |
132 | Phosphorylation | EKVQRKGTTSYNEVA HHHHHHCCCCHHHHH | 18.66 | 26552605 | |
133 | Phosphorylation | KVQRKGTTSYNEVAD HHHHHCCCCHHHHHH | 37.57 | 26552605 | |
134 | Phosphorylation | VQRKGTTSYNEVADE HHHHCCCCHHHHHHH | 26.29 | 26552605 | |
135 | Phosphorylation | QRKGTTSYNEVADEL HHHCCCCHHHHHHHH | 17.16 | 26552605 | |
139 | Ubiquitination | TTSYNEVADELVAEF CCCHHHHHHHHHHHH | 9.81 | - | |
147 | Phosphorylation | DELVAEFSAADNHIL HHHHHHHHHHCCCCC | 17.66 | 26552605 | |
158 | Phosphorylation | NHILPNESAYDQKNI CCCCCCCCCCCCHHH | 38.48 | 26552605 | |
160 | Phosphorylation | ILPNESAYDQKNIRR CCCCCCCCCCHHHHH | 28.34 | 26552605 | |
163 | Ubiquitination | NESAYDQKNIRRRVY CCCCCCCHHHHHHHH | 51.98 | - | |
170 | Phosphorylation | KNIRRRVYDALNVLM HHHHHHHHHHHHHHH | 8.16 | 25072903 | |
180 | N-linked_Glycosylation | LNVLMAMNIISKEKK HHHHHHHHHHCCCCC | 20.92 | - | |
180 | N-linked_Glycosylation | LNVLMAMNIISKEKK HHHHHHHHHHCCCCC | 20.92 | 19349973 | |
183 | Phosphorylation | LMAMNIISKEKKEIK HHHHHHHCCCCCCCE | 30.85 | 22817900 | |
190 | Ubiquitination | SKEKKEIKWIGLPTN CCCCCCCEEEECCCC | 33.57 | - | |
217 | Ubiquitination | QRRLERIKQKQSQLQ HHHHHHHHHHHHHHH | 58.63 | - | |
219 | Ubiquitination | RLERIKQKQSQLQEL HHHHHHHHHHHHHHH | 47.09 | - | |
221 | Phosphorylation | ERIKQKQSQLQELIL HHHHHHHHHHHHHHH | 39.63 | - | |
225 | Ubiquitination | QKQSQLQELILQQIA HHHHHHHHHHHHHHH | 46.50 | - | |
234 | Ubiquitination | ILQQIAFKNLVQRNR HHHHHHHHHHHHHHH | 40.11 | - | |
248 | Phosphorylation | RHAEQQASRPPPPNS HHHHHHHCCCCCCCC | 40.77 | 28787133 | |
301 | Acetylation | HDDIEVLKRMGMACG CCHHHHHHHCCCCCC | 45.58 | 7683649 | |
311 | Phosphorylation | GMACGLESGSCSAED CCCCCCCCCCCCHHH | 40.84 | 27732954 | |
313 | Phosphorylation | ACGLESGSCSAEDLK CCCCCCCCCCHHHHH | 17.74 | 27732954 | |
315 | Phosphorylation | GLESGSCSAEDLKMA CCCCCCCCHHHHHHH | 36.07 | 27732954 | |
320 | Ubiquitination | SCSAEDLKMARSLVP CCCHHHHHHHHHHCH | 42.72 | 21890473 | |
360 | Phosphorylation | TSNGTRFSASDLTNG CCCCCEECHHHCCCC | 24.46 | 27251275 | |
362 | Phosphorylation | NGTRFSASDLTNGAD CCCEECHHHCCCCCC | 31.77 | 27251275 | |
365 | Phosphorylation | RFSASDLTNGADGML EECHHHCCCCCCCCE | 36.27 | 27251275 | |
374 | Phosphorylation | GADGMLATSSNGSQY CCCCCEEECCCCCCC | 28.82 | 27251275 | |
375 | Phosphorylation | ADGMLATSSNGSQYS CCCCEEECCCCCCCC | 19.05 | 26714015 | |
376 | Phosphorylation | DGMLATSSNGSQYSG CCCEEECCCCCCCCC | 40.64 | 27251275 | |
379 | Phosphorylation | LATSSNGSQYSGSRV EEECCCCCCCCCCCE | 30.14 | 27251275 | |
381 | Phosphorylation | TSSNGSQYSGSRVET ECCCCCCCCCCCEEC | 19.39 | 27251275 | |
382 | Phosphorylation | SSNGSQYSGSRVETP CCCCCCCCCCCEECC | 23.74 | 27251275 | |
384 | Phosphorylation | NGSQYSGSRVETPVS CCCCCCCCCEECCCE | 27.49 | 27251275 | |
388 | Phosphorylation | YSGSRVETPVSYVGE CCCCCEECCCEECCC | 26.57 | 28985074 | |
391 | Phosphorylation | SRVETPVSYVGEDDE CCEECCCEECCCCCC | 18.46 | 28985074 | |
392 | Phosphorylation | RVETPVSYVGEDDEE CEECCCEECCCCCCC | 16.83 | 27732954 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
23 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TFDP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TFDP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TP53B_HUMAN | TP53BP1 | physical | 8896460 | |
CDK3_HUMAN | CDK3 | physical | 8846921 | |
E2F1_HUMAN | E2F1 | physical | 7892279 | |
E2F4_HUMAN | E2F4 | physical | 7892279 | |
E2F5_HUMAN | E2F5 | physical | 7892279 | |
E2F1_HUMAN | E2F1 | physical | 22629304 | |
E2F1_HUMAN | E2F1 | physical | 9199321 | |
E2F4_HUMAN | E2F4 | physical | 9199321 | |
E2F1_HUMAN | E2F1 | physical | 8816798 | |
E2F6_HUMAN | E2F6 | physical | 9704927 | |
E2F1_HUMAN | E2F1 | physical | 9704927 | |
E2F1_HUMAN | E2F1 | physical | 8832394 | |
E2F2_HUMAN | E2F2 | physical | 8832394 | |
E2F3_HUMAN | E2F3 | physical | 8832394 | |
CBP_HUMAN | CREBBP | physical | 8932363 | |
E2F1_HUMAN | E2F1 | physical | 15133492 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. |